ACE2 and COVID-19: The COVID-19 patients show stratified symptoms, including asymptomatic, mild, moderate, and severe.2 Using RBD–ACE2 blockade, pseudovirus neutralization, and authentic virus neutralization, we observed that disease severity positively correlates to NAb responses.